Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Aprea Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 22 | 27 | +5 |
| Shares | 2.24M | 2.37M | +126.5K (+5.6%) |
| Value | $1.71M | $1.90M | +$189.9K (+11.1%) |
New holders (7)
Institutions that held Aprea Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 58,600 | $47.0K | 0.00% |
| Diadema Partners LP | 44,907 | $36.0K | 0.01% |
| Northern Trust Corp | 13,705 | $11.0K | 0.00% |
| Persistent Asset Partners Ltd | 11,490 | $9.22K | 0.00% |
| XTX Topco Ltd | 10,565 | $8.48K | 0.00% |
| Barclays PLC | 473 | $379 | 0.00% |
| FMR LLC | 45 | $36 | 0.00% |
Sold out (2)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Scientech Research LLC | 60,281 | $46.0K |
| Two Sigma Securities, LLC | 13,500 | $10.3K |